“GLP-1 RECEPTOR AGONISTS BEYOND OBESITY: EXPANDING HORIZONS IN CARDIOMETABOLIC, RENAL, AND NEUROLOGICAL DISEASE”. 2026. International Journal of Medical Sciences 6 (4): 849-55. https://doi.org/10.55640/.